Valeo Financial Advisors’s Oncternal Therapeutics, Inc. Common Stock ONCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-1,177
| Closed | -$12.6K | – | 680 |
|
|
2023
Q4 | $12.6K | Sell |
1,177
-550
| -32% | -$5.9K | ﹤0.01% | 631 |
|
|
2023
Q3 | $10.4K | Hold |
1,727
| – | – | ﹤0.01% | 614 |
|
|
2023
Q2 | $11.9K | Hold |
1,727
| – | – | ﹤0.01% | 587 |
|
|
2023
Q1 | $27.1K | Hold |
1,727
| – | – | ﹤0.01% | 598 |
|
|
2022
Q4 | $34.5K | Hold |
1,727
| – | – | ﹤0.01% | 521 |
|
|
2022
Q3 | $31K | Hold |
1,727
| – | – | ﹤0.01% | 471 |
|
|
2022
Q2 | $38K | Hold |
1,727
| – | – | ﹤0.01% | 466 |
|
|
2022
Q1 | $48K | Hold |
1,727
| – | – | ﹤0.01% | 561 |
|
|
2021
Q4 | $78K | Hold |
1,727
| – | – | ﹤0.01% | 523 |
|
|
2021
Q3 | $144K | Buy |
+1,727
| New | +$144K | 0.01% | 492 |
|
|
2021
Q2 | – | Sell |
-175
| Closed | -$29K | – | 1851 |
|
|
2021
Q1 | $29K | Buy |
+175
| New | +$29K | ﹤0.01% | 995 |
|